Coalition of liver associations call for simplifying hepatitis C care
Dolutegravir and raltegravir cause changes to fat cells
Weight gain after switching to integrase inhibitor treatment is small in Dutch and Swiss cohorts
French study finds one in six stops PrEP within 12 months, one in three after 30 months
New European HIV guidelines cater for multiple needs
Anal cancer: Australian study of precancerous tissues in gay men shows little increased risk in positive men, almost no cancer cases
ADVANCE study shows high frequency of major weight gain in women receiving dolutegravir with TAF
Weight gain on HIV treatment: drug combinations, not single drugs, need to be focus of quest for cause
Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe
